1. Home
  2. LMRI vs INVA Comparison

LMRI vs INVA Comparison

Compare LMRI & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LMRI

Lumexa Imaging Holdings Inc. Common Stock

N/A

Current Price

$14.44

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo Innoviva Inc.

INVA

Innoviva Inc.

HOLD

Current Price

$19.57

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMRI
INVA
Founded
2018
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2025
2004

Fundamental Metrics

Financial Performance
Metric
LMRI
INVA
Price
$14.44
$19.57
Analyst Decision
Strong Buy
Buy
Analyst Count
4
5
Target Price
$22.67
$36.80
AVG Volume (30 Days)
621.0K
612.7K
Earning Date
01-01-0001
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.96
EPS
N/A
1.52
Revenue
$1,003,375,000.00
$388,521,000.00
Revenue This Year
$9.29
$13.23
Revenue Next Year
$5.01
$8.58
P/E Ratio
N/A
$12.83
Revenue Growth
1.38
10.14
52 Week Low
$14.00
$16.52
52 Week High
$19.45
$22.76

Technical Indicators

Market Signals
Indicator
LMRI
INVA
Relative Strength Index (RSI) N/A 44.85
Support Level N/A $19.29
Resistance Level N/A $20.04
Average True Range (ATR) 0.00 0.50
MACD 0.00 0.03
Stochastic Oscillator 0.00 45.94

Price Performance

Historical Comparison
LMRI
INVA

About LMRI Lumexa Imaging Holdings Inc. Common Stock

Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.

About INVA Innoviva Inc.

Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Share on Social Networks: